This message is being sent as part of CAPhO’s Email Distribution Service on behalf of Agence Unik and is not an endorsement or recommendation of the product or message content.
Dear Healthcare Professional,
You are invited to a virtual interactive session titled Elevating the Role of Nurses & Pharmacists within the Myelofibrosis Multidisciplinary Team, designed to foster collaboration between nurses and pharmacists in the management of myelofibrosis (MF).
This session will highlight the value of a shared care model, offer practical strategies to enhance patient outcomes, and explore the myelofibrosis journey—from diagnosis through ongoing care.
Learning Objectives:
- Recognize and describe common challenges and burdens that impact quality of life for myelofibrosis (MF) patients.
- Differentiate the clinical and pharmacological characteristics of JAK inhibitors to support optimal treatment and patient management.
- Apply practical strategies for treating and managing myelofibrosis patients through a case-based approach within the multidisciplinary team.
Co-presenters:
Clinical Nurse Specialist
Senior Hematology Pharmacist
| Date | Time |
| Friday, August 15 | 12:00 – 1:00 PM PT |
| Monday, September 8 | 7:00 – 8:00 PM AT |
| Wednesday, September 10 | 7:00 – 8:00 PM ET |
| Thursday, September 25 | 7:00 – 8:00 PM ET |
Sincerely,
The Canadian Council on Continuing Education in Pharmacy has accredited the program for 1.5 CEU.
The program is under review with the Canadian Nurses Association for accreditation.
This program was made possible through the Master Clinician Alliance (MCA), which graciously acknowledges the education grant and in-kind support provided by GlaxoSmithKline.